
FRIDAY, Aug. 4, 2023 (HealthDay News) – The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respiratory syncytial virus (RSV). The antibody shot, sold as Beyfortus, has been shown to reduce the risk… read on > read on >